Debasish Roychowdhury - Articles and news items


Curie-Cancer and Sanofi cooperate in research on ovarian cancer

Industry news, News / 19 June 2013 / Sanofi

Preclinical program of translational research to identify new target proteins…


ZALTRAP® (aflibercept) approved in the EU

Industry news, News / 5 February 2013 / Sanofi

First and only agent to statistically significantly improve survival in combination with FOLFIRI chemotherapy after an oxaliplatin regimen…


Phase II Trial of Sanofi JAK2 inhibitor in myelofibrosis met primary endpoint

Industry news, News / 9 December 2012 / Sanofi

New data presented at American Society of Hematology Annual Meeting show activity against disease and symptom alleviation…


Sanofi compounds to be featured in 178 abstracts at American Society of Hematology Annual Meeting

Industry news, News / 3 December 2012 / Sanofi

American Society of Hematology, Atlanta, GA., 8-11 December, 2012…


ZALTRAP® receives CHMP positive opinion in the European Union for previously treated mCRC

Industry news, News / 16 November 2012 / Sanofi

“We are pleased that CHMP has supported our ZALTRAP application…”

Journal of Clinical Oncology publishes Phase III results of ZALTRAP® (aflibercept) VELOUR study

Industry news, News / 8 October 2012 / Sanofi

Results from the pivotal Phase III VELOUR study…

ASCO abstracts highlight late-stage Sanofi Oncology pipeline

Industry news, News / 16 May 2012 / Sanofi

Progress on Jevtana®, Zaltrap™ and JAK2 inhibitor featured…

Sanofi and Regeneron announce regulatory and clinical update for Zaltrap® (aflibercept)

Industry news, News / 5 April 2012 / Sanofi

The FDA has granted Priority Review of the BLA for the investigational agent Zaltrap®…

New data in breast and ovarian cancer presented at ASCO support continued development of Iniparib

Industry news, News / 6 June 2011 / Sanofi

Sanofi announced new data for iniparib (BSI-201)…

ZALTRAP™ (aflibercept) significantly improved survival in previously treated metastatic colorectal cancer patients

Industry news, News / 6 June 2011 / Sanofi

Data will be presented at the ESMO World Congress on Gastrointestinal Cancer…


The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...